Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Acadia, Ascentage, Immutep, Neuren, Zydus Cadila.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Dianosic, Keystone Heart.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bellerophon, Cadent, Daré, Freeline.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: CMR, Livanova, Syncardia Systems.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Ascentage, Athenex, Avrobio, Boehringer Ingelheim, F2G, Immutep, Mylan, Nicox, Novartis, Pharming, Valneva.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Neuronetics, Stereotaxis.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Nicox.

The latest global regulatory news, changes and updates affecting medical devices and technologies, including: Aerin Medical, Biogennix, Calcivis, Cryolife, Magnolia Medical, Reflow Medical, V-Wave.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Allergan, Cardiol, Outlook, TG, Urovant, Zydus.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Roche.